Company intelligence / Profile preview

Oresund Pharma

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Oresund Pharma focuses on the distribution and in‐licensing of medicines for the Nordic region, with a business model centered on partnerships and efficient supply. The company distributes both niche and established pharmaceutical products, including small molecules like methotrexate. There are no publicly disclosed proprietary clinical results; their pipeline appears to be based on licensing/distribution rather than internal R&D.

Therapeutic areas: Infectious DiseasesImmunologyNeurologyHematology
Modalities: Small molecule drugsChemical drugs
Industry: Biotech

Partnerships

Not specifically named, but the business model is partnership-driven for distribution and in‐licensing across the Nordic region.

Beyond the preview

Go deeper on Oresund Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oresund Pharma.

Explore the full profile